Vitamin D2 Ergocalciferol Encyclopedia — Scientific Background

What Is Ergocalciferol?

Ergocalciferol (CAS 50-14-6), also known as vitamin D2, calciferol, or oleovitamin D2, is a fat-soluble secosteroid with the molecular formula C₂₈H₄₄O and a molecular weight of 396.65 g/mol. It is chemically designated as (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol. Ergocalciferol occurs as white or slightly yellowish, odorless crystalline powder or white to almost white crystals, and is practically insoluble in water but freely soluble in ethanol (96%) and methanol, and soluble in fatty oils. It is sensitive to air, heat, and light, and undergoes reversible isomerization to pre-ergocalciferol in solution depending on temperature and time, with the activity attributed to both compounds.

The Two Forms of Vitamin D

Vitamin D exists in two primary forms, which are structurally similar but differ in their source and side chain structure:

Vitamin D2 (Ergocalciferol) — Produced by ultraviolet irradiation of ergosterol in plants, fungi, and yeast. It is the primary form of vitamin D used in food fortification and is suitable for vegan and vegetarian applications. Vitamin D2 is also available as a pharmaceutical agent for the treatment of vitamin D deficiency.

Vitamin D3 (Cholecalciferol) — Produced in the skin of animals and humans upon exposure to UVB radiation from sunlight, and obtained through dietary intake from animal sources such as fatty fish and egg yolks. Vitamin D3 is often considered to have superior bioavailability compared to D2.

Both forms are metabolized in the liver to 25-hydroxyvitamin D (25(OH)D), the primary circulating form used to assess vitamin D status, and then in the kidneys to the biologically active form, 1,25-dihydroxyvitamin D.

Physiological Functions of Vitamin D2

Vitamin D2 is critical for numerous physiological functions:

• Calcium and Phosphorus Homeostasis — Vitamin D2 promotes intestinal calcium absorption and renal calcium reabsorption, maintaining normal serum calcium and phosphorus levels essential for bone mineralization and neuromuscular function.

• Bone Health — Vitamin D2 supports bone mineralization and is essential for the prevention and treatment of rickets in children and osteomalacia in adults.

• Immune Function — Vitamin D2 modulates both innate and adaptive immune responses, supporting the body's natural defense mechanisms.

• Neuromuscular Function — Vitamin D2 contributes to normal muscle function and neuromuscular signaling.

• Cell Growth and Differentiation — Vitamin D2 regulates cell growth, differentiation, and apoptosis, supporting normal cellular function.

Mechanisms of Action

Vitamin D Receptor (VDR) Signaling

Vitamin D2 is metabolized to 25-hydroxyvitamin D2 in the liver and then to the biologically active 1,25-dihydroxyvitamin D2 in the kidneys. The active metabolite binds to the vitamin D receptor (VDR), a nuclear receptor that regulates the transcription of target genes involved in calcium and phosphorus homeostasis, bone metabolism, immune function, and cell growth.

Calcium Absorption and Bone Mineralization

Vitamin D2 enhances intestinal calcium absorption by increasing the expression of calcium transport proteins, including TRPV6 and calbindin-D9k, in the intestinal epithelium. It also promotes renal calcium reabsorption and regulates parathyroid hormone (PTH) secretion, maintaining normal calcium homeostasis essential for bone mineralization.

Immune Modulation

Vitamin D2 modulates immune function by regulating the activity of immune cells, including T lymphocytes, macrophages, and dendritic cells. It enhances the antimicrobial activity of monocytes and macrophages and modulates cytokine production, supporting both innate and adaptive immune responses.

The Bioavailability Challenge

Despite its essential physiological functions, conventional oral ergocalciferol presents significant bioavailability challenges. The compound is highly lipophilic and requires bile salt-dependent micelle formation for intestinal absorption. Its oral bioavailability is influenced by dietary fat intake and individual gastrointestinal conditions. Additionally, ergocalciferol is sensitive to air, heat, and light, and undergoes reversible isomerization to pre-ergocalciferol in solution, which can compromise its stability and potency during storage.

These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. liposomes have demonstrated significant promise for encapsulating lipophilic bioactives and improving their bioaccessibility. Vitamin D2 can be incorporated into phospholipid liposomes at concentrations up to approximately 35 wt.%, providing a stable and homogeneous formulation.

Liposomal vitamin D2

Liposomal encapsulation of ergocalciferol provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the ergocalciferol molecule, forming a protective shell that enhances stability, bioaccessibility, and cellular uptake. This delivery system:

• Protects ergocalciferol from air, heat, and light-induced degradation and isomerization

• Enhances dispersion and absorption of this fat-soluble vitamin in aqueous environments

• Achieves incorporation levels up to approximately 35 wt.% in phospholipid liposomes

• Provides sustained release for prolonged vitamin D activity

• Enhances cellular uptake through membrane fusion and lipid-mediated pathways

Clinical Evidence

Vitamin D Deficiency Treatment — Clinical Guidelines

Ergocalciferol is indicated for the prophylaxis and treatment of vitamin D deficiency, including rickets, osteomalacia, and neonatal hypocalcemia. For the treatment of deficiency, the recommended dose is 2,000–4,000 IU/day for 3–6 months. High-dose protocols may include 50,000 IU weekly for 8 weeks or a single dose of 200,000 IU. Vitamin D2, if given in high enough doses, prevents infantile rickets and is capable of healing adult osteomalacia.

Bioavailability Comparison — Vitamin D2 vs. D3

A randomized controlled trial compared the bioavailability of vitamin D2 and D3 in healthy volunteers when consumed at different levels in a malt drink. The study investigated whether the seasonal fall in serum 25-hydroxyvitamin D concentrations could be prevented by regular consumption of ergocalciferol or cholecalciferol in a fortified drink. The study design was a parallel, randomized, placebo-controlled, double-blind trial.

Food Fortification — Clinical Applications

Ergocalciferol is the primary form of vitamin D used in food fortification, including beverages, dairy products, cereals, and infant formula. Food fortification programs using vitamin D2 have demonstrated measurable improvements in vitamin D status in populations at risk of deficiency.

Safety and Regulatory

Ergocalciferol has a well-established safety profile when used appropriately. The Tolerable Upper Intake Level (UL) for vitamin D is 4,000 IU/day for adults, although higher doses may be used under medical supervision. Excessive intake of vitamin D can cause hypercalcemia, which may result in nausea, vomiting, weakness, and renal complications.

Regulatory Status:

• United States — Ergocalciferol is regulated as a dietary supplement ingredient and pharmaceutical agent. It is Generally Recognized As Safe (GRAS) for use in food and dietary supplements. It is monographed in the USP with an assay specification of 97.0%–103.0% on the anhydrous basis. It is the primary form of vitamin D used in food fortification.

• European Union — Ergocalciferol is monographed in the European Pharmacopoeia (Ph. Eur. monograph 0082) and is authorized as a vitamin and mineral substance which may be used in the manufacture of food supplements. It is permitted for use in food fortification in EU member states.

• United Kingdom — Ergocalciferol is included in the British Pharmacopoeia (BP 2025) with an assay specification of 97.0%–102.0%.

• Global Standards — Ergocalciferol is monographed in the USP, European Pharmacopoeia, British Pharmacopoeia, and Japanese Pharmacopoeia. It is available with Halal and Kosher certifications. The product complies with USP/EP/BP specifications including specific optical rotation (+103° to +107°), specific absorbance at 265 nm (445–485), and melting point (115–119°C).

Precautions: Ergocalciferol is generally well tolerated at recommended doses. Excessive intake of vitamin D can cause hypercalcemia, which may result in nausea, vomiting, weakness, and renal complications. Individuals with hypercalcemia, hyperphosphatemia, or severe renal impairment should consult a healthcare professional before use. Pregnant or lactating women and children should consult a healthcare professional before use. Ergocalciferol may interact with certain medications, including thiazide diuretics, cardiac glycosides, and corticosteroids.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, British Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

199$/KG

99$/KG